Dr Joe Taylor considers the implications of personalised pharmacotherapy for life sciences and healthcare.
Candesic is a leading strategy consultancy
head-quartered in London, serving private operators, investors, and public sector organisations.
Candesic is shining a spotlight on women`s health
Candesic is shining a spotlight on women`s health. Michelle Tempest has been quoted in the latest LaingBuisson issue in an article by Hamid Yunis. Michelle comments on attitudes towards women`s health, the difficult route of female entrepreneurs and how a jointed investment climate can change that. Click on the link to read the full article.
Michelle Tempest chairing the Royal Society of Medicine event
Yesterday Candesic attended the Royal Society of Medicine event to discuss digital therapeutics and the [o](https://www.linkedin.com/feed/hashtag/?keywords=opportunities&highlightedUpdateUrns=urn%3Ali%3Aactivity%3A7021786260000145408)pportunities to improve patient experience and outcomes. Candesic partner Michelle Tempest was chairing a discussion about regulation, investment and reimbursement alongside Megan Coder, Hakim Yadi and Ifran Hassan. The event brought together a brilliant team of experts: Dr Hugh Harvey, Julia Manning, Dr Harpreet Sood, Professor Sultan Mahmud, Tony Bowden, Tim Ringrose, John O`Dowd, Camille Carroll, Hilary Nathan, Andy Jones, Liz Ashall-Payne, Dave Taylor, Dan Lock, Heather Cook, Cristina Ortega Duran, Richard Sargeant and James Wilson.
Candesic starting new year with IPEM Cannes 2023
Candesic is starting 2023 with apparence at IPEM Cannes conference where we will be discussing upcoming opportunities and challenges.
© Candesic 2023